The need for remote access to healthcare over the past few years had shifted how the entire healthcare industry provided care outside the walls of a medical facility.

As global biotech investment has cooled since the biotech bull market of 2021, some companies have looked to cut more than 25% of their staff.

As General Catalyst looks to expand its healthcare presence to actually own and operate a health system, it has tapped former hospital CEOs into key leadership positions.

The Biden administration has taken on a worthy adversary with its "moonshot" goal of halving cancer deaths over the next 25 years and, in the process, saving 4 million lives. But what other "moonshot" projects would healthcare leaders take on?

A survey of 2,014 adults from consulting giant Deloitte found that 53% believe generative artificial intelligence could improve access to healthcare.

General Catalyst's Head of the Health Assurance Ecosystem Daryl Tol said that despite the "very frustrating" healthcare industry, the investment firm is still going to "put a stake in the ground with healthcare systems," Yahoo Finance reported Nov. 14.

Trip Hofer, the former CEO of Optum Behavioral Health Solutions, joined healthcare venture capital firm .406 Ventures as a venture partner.

University of Miami Health System will implement AI from Aidoc to detect potential issues at the initial stages of care, streamline workflows and facilitate ongoing support throughout the post-diagnosis phase.

Software and IT companies Salesforce and Accenture are partnering to bring generative artificial intelligence tools to healthcare, life sciences and biopharma companies.

Fifty-one percent of U.S. adults expressed optimism about the potential for new applications of artificial intelligence to drive significant advancements and breakthroughs in healthcare in the coming year, a recent survey from Medtronic and Morning Consult found. 

Two giants in their industries are joining forces.

Houston-based University of Texas MD Anderson Cancer Center has launched a huge data science project to advance oncology treatment, research and patient experience.

Nashville, Tenn.-based Vanderbilt University Medical Center and Durham, N.C. Duke University School of Medicine have received a $1.25 million grant from the Gordon and Betty Moore Foundation to enhance the supervision of AI technology within healthcare systems.

To unlock an operating room's full potential, building trust and engagement with surgeons is essential.

Emory University, based in Atlanta, has launched the Emory Empathetic AI for Health Institute, an institute dedicated to using artificial intelligence and computing power to extract meaningful insights from massive amounts of data and forecast outcomes that enhance patient well-being across various diseases.

Sangamo Therapeutics, a biotech company developing treatment for genetic conditions, announced that it is laying off 162 employees, or 40% of the company's U.S. workforce, as the company looks to restructure and focus on the creation of neurological treatments.

Oakland, Calif.-based Kaiser Permanente has been developing artificial intelligence tools that track patient deterioration for more than a decade, The Washington Post reported Nov. 7.

Some hospital leaders are optimistic that artificial intelligence could liberate their clinicians from hours of administrative work and return them to the bedside.

Cleveland Clinic is accelerating its pace with quantum computing as it looks to explore how quantum computing can optimize healthcare's complex systems and drug discovery as well as see if it can provide more accuracy than AI models. 

Despite the souring digital health venture market, large health systems with investment arms, such as Cleveland Clinic and Memorial Hermann, have still been active in financing innovative medtech companies.